Drugs / Measles, Mumps, Rubella and Chickenpox (live vaccine)
Measles, Mumps, Rubella and Chickenpox (live vaccine)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT00127023 | May → Nov 2005 | measles, mumps infectious disease, rubella, varicella zoster infection | GlaxoSmithKline | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Measles, Mumps, Rubella and Chickenpox (live vaccine) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00127023 ↗ |
| Modality | Vaccine | “combined measles-mumps-rubella varicella candidate vaccine” NCT00127023 ↗ |